Filter posts

The Future of Biodefense: Will Public-Private Partnerships Continue?

Ten years ago, in the wake of the 2001 anthrax attacks, the U.S. government set …

Inter Partes Review – a Useful Tool for Overcoming Freedom-to-Operate Obstacles

By Eric K. Steffe, Eldora L. Ellison, Ph.D., Todd Spalding, and Deborah A. Sterling, Ph.D. …

Academics to be Featured at the 2013 BIO Alliance Pavilion

I think it safe to say that the U.S. biotechnology industry has its R&D roots …

SIPO Examiner Workshop: Biotech Patent Practices in the U.S., China and Japan

The biotechnology industry is an invention-intensive industry that relies heavily on the protection of intellectual …

It’s World Polio Day – Time to Make History

Oct. 24 is World Polio Day, an opportunity to share a message of extreme importance: …

Pharma & Biotech Companies Donate Hundreds of Millions of Dollars to Copayment Foundations. Here’s...

In addition to using their own Patient Assistance Programs, many pharma and biotech companies are …

What Will It Take for the U.S. to Maintain Leadership in the Biopharma Industry?

The biopharmaceutical industry is an important contributor to U.S. economic growth and sustainability, with more …

Creating a Preparedness Plan: A Good Investment

No one thinks that their company may be affected by a flood, earthquake or other …

Childhood Cancer Groups Join Forces to Train Childhood Cancer Leaders

Cancer remains the leading cause of death by disease for children in the United States …

The Importance of Encouraging Adult Vaccination This Fall

As National Immunization Awareness Month ends and flu season approaches, many adults around the country …